Contact Information

Call us at: (614)722-6881

Fax us at: (614)722-6746

Clinical Therapies700 Children’s Dr.Columbus, OH 43205 (map)

Learn more about Natalie F Reash

Biography

Natalie Reash, PT, DPT, works in the Research Institute’s Center for Gene Therapy, MDA Clinic and SMA Clinic. Her interests are focused on improving functional outcomes for children with developmental disabilities and researching outcome measures and exercise in children and adults with neuromuscular disease. Natalie has been a member of the American Physical Therapy Association and the Section on Pediatrics since 2012.

Academic and Clinical Areas

Physical Therapy

Developmental Physical Therapy Team

Primary Department

Clinical Therapies

Research

Publications

                  James MK, Alfano LN, Muni-Lofra R, Reash NF, Sodhi J, Iammarino MA, Moat D, Shannon K, McCallum M, Richardson M, Eagle M, Straub V, Marini-Bettolo C, Lowes LP, Mayhew AG. Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies. Phys Ther. 2022 Aug 6;  

                


                  Reash NF, James MK, Alfano LN, Mayhew AG, Jacobs M, Iammarino MA, Holsten S, Sakamoto C, Tateishi T, Yajima H, Duong T, de Wolf B, Gee R, Bharucha-Goebel DX, Bravver E, Mori-Yoshimura M, Bushby K, Rufibach LE, Straub V, Lowes LP, Jain COS Consortium.. Comparison of strength testing modalities in dysferlinopathy. Muscle Nerve. 2022 May 4;  

                


                  Contesse MG, Lowes LP, White MK, Dalle Pazze L, McSherry C, Alfano LN, Iammarino M, Reash N, Bonarrigo K, Kiefer M, Laubscher K, McIntyre M, Mockler S, Nelson L, Vogel L, Leffler MG. Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy. PLoS One. 2022; 17: e0266845.

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  James MK, Rose K, Alfano LN, Reash NF, Eagle M, Lowes LP. Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic. Front Genet. 2021; 12: 735538.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Mendell JR, Chicoine LG, Al-Zaidy SA, Sahenk Z, Lehman K, Lowes L, Miller N, Alfano L, Galliers B, Lewis S, Murrey D, Peterson E, Griffin DA, Church K, Cheatham S, Cheatham J, Hogan MJ, Rodino-Klapac LR. Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb Infusion. Hum Gene Ther. 2019 Apr 19;  

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Mendell JR, Sahenk Z, Al-Zaidy S, Rodino-Klapac LR, Lowes LP, Alfano LN, Berry K, Miller N, Yalvac M, Dvorchik I, Moore-Clingenpeel M, Flanigan KM, Church K, Shontz K, Curry C, Lewis S, McColly M, Hogan MJ, Kaspar BK. Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes. Mol Ther. 2017 Apr 5; 25: 870-879.

View More Publications

Contact Information

Clinical Therapies

Call us at: (614)722-6881

Fax us at: (614)722-6746

                    700 Children's Dr.Columbus, OH 43205 (map)

Contact Information

Call us at: (614)722-6881

Fax us at: (614)722-6746

Clinical Therapies700 Children’s Dr.Columbus, OH 43205 (map)

Learn more about Natalie F Reash

Biography

Natalie Reash, PT, DPT, works in the Research Institute’s Center for Gene Therapy, MDA Clinic and SMA Clinic. Her interests are focused on improving functional outcomes for children with developmental disabilities and researching outcome measures and exercise in children and adults with neuromuscular disease. Natalie has been a member of the American Physical Therapy Association and the Section on Pediatrics since 2012.

Academic and Clinical Areas

Physical Therapy

Developmental Physical Therapy Team

Primary Department

Clinical Therapies

Research

Publications

                  James MK, Alfano LN, Muni-Lofra R, Reash NF, Sodhi J, Iammarino MA, Moat D, Shannon K, McCallum M, Richardson M, Eagle M, Straub V, Marini-Bettolo C, Lowes LP, Mayhew AG. Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies. Phys Ther. 2022 Aug 6;  

                


                  Reash NF, James MK, Alfano LN, Mayhew AG, Jacobs M, Iammarino MA, Holsten S, Sakamoto C, Tateishi T, Yajima H, Duong T, de Wolf B, Gee R, Bharucha-Goebel DX, Bravver E, Mori-Yoshimura M, Bushby K, Rufibach LE, Straub V, Lowes LP, Jain COS Consortium.. Comparison of strength testing modalities in dysferlinopathy. Muscle Nerve. 2022 May 4;  

                


                  Contesse MG, Lowes LP, White MK, Dalle Pazze L, McSherry C, Alfano LN, Iammarino M, Reash N, Bonarrigo K, Kiefer M, Laubscher K, McIntyre M, Mockler S, Nelson L, Vogel L, Leffler MG. Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy. PLoS One. 2022; 17: e0266845.

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  James MK, Rose K, Alfano LN, Reash NF, Eagle M, Lowes LP. Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic. Front Genet. 2021; 12: 735538.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Mendell JR, Chicoine LG, Al-Zaidy SA, Sahenk Z, Lehman K, Lowes L, Miller N, Alfano L, Galliers B, Lewis S, Murrey D, Peterson E, Griffin DA, Church K, Cheatham S, Cheatham J, Hogan MJ, Rodino-Klapac LR. Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb Infusion. Hum Gene Ther. 2019 Apr 19;  

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Mendell JR, Sahenk Z, Al-Zaidy S, Rodino-Klapac LR, Lowes LP, Alfano LN, Berry K, Miller N, Yalvac M, Dvorchik I, Moore-Clingenpeel M, Flanigan KM, Church K, Shontz K, Curry C, Lewis S, McColly M, Hogan MJ, Kaspar BK. Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes. Mol Ther. 2017 Apr 5; 25: 870-879.

View More Publications

Contact Information

Clinical Therapies

Call us at: (614)722-6881

Fax us at: (614)722-6746

                    700 Children's Dr.Columbus, OH 43205 (map)

Contact Information

Call us at: (614)722-6881

Fax us at: (614)722-6746

Clinical Therapies700 Children’s Dr.Columbus, OH 43205 (map)

Learn more about Natalie F Reash

Contact Information

  • Call us at:
  • (614)722-6881
  • Fax us at:
  • (614)722-6746
  • Clinical Therapies700 Children’s Dr.Columbus, OH 43205 (map)

Learn more about Natalie F Reash

Biography

Natalie Reash, PT, DPT, works in the Research Institute’s Center for Gene Therapy, MDA Clinic and SMA Clinic. Her interests are focused on improving functional outcomes for children with developmental disabilities and researching outcome measures and exercise in children and adults with neuromuscular disease. Natalie has been a member of the American Physical Therapy Association and the Section on Pediatrics since 2012.

Biography

Natalie Reash, PT, DPT, works in the Research Institute’s Center for Gene Therapy, MDA Clinic and SMA Clinic. Her interests are focused on improving functional outcomes for children with developmental disabilities and researching outcome measures and exercise in children and adults with neuromuscular disease. Natalie has been a member of the American Physical Therapy Association and the Section on Pediatrics since 2012.

Biography

Natalie Reash, PT, DPT, works in the Research Institute’s Center for Gene Therapy, MDA Clinic and SMA Clinic. Her interests are focused on improving functional outcomes for children with developmental disabilities and researching outcome measures and exercise in children and adults with neuromuscular disease. Natalie has been a member of the American Physical Therapy Association and the Section on Pediatrics since 2012.

Natalie Reash, PT, DPT, works in the Research Institute’s Center for Gene Therapy, MDA Clinic and SMA Clinic. Her interests are focused on improving functional outcomes for children with developmental disabilities and researching outcome measures and exercise in children and adults with neuromuscular disease. Natalie has been a member of the American Physical Therapy Association and the Section on Pediatrics since 2012.

Natalie Reash, PT, DPT, works in the Research Institute’s Center for Gene Therapy, MDA Clinic and SMA Clinic. Her interests are focused on improving functional outcomes for children with developmental disabilities and researching outcome measures and exercise in children and adults with neuromuscular disease. Natalie has been a member of the American Physical Therapy Association and the Section on Pediatrics since 2012.

Academic and Clinical Areas

Physical Therapy

Developmental Physical Therapy Team

Primary Department

Clinical Therapies

Academic and Clinical Areas

Physical Therapy

Developmental Physical Therapy Team

Primary Department

Clinical Therapies

Academic and Clinical Areas

Physical Therapy

Developmental Physical Therapy Team

Primary Department

Clinical Therapies

Physical Therapy

Developmental Physical Therapy Team

Primary Department

Clinical Therapies

  • Physical Therapy
  • Developmental Physical Therapy Team
  • Primary Department
  • Clinical Therapies

Research

Publications

                  James MK, Alfano LN, Muni-Lofra R, Reash NF, Sodhi J, Iammarino MA, Moat D, Shannon K, McCallum M, Richardson M, Eagle M, Straub V, Marini-Bettolo C, Lowes LP, Mayhew AG. Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies. Phys Ther. 2022 Aug 6;  

                


                  Reash NF, James MK, Alfano LN, Mayhew AG, Jacobs M, Iammarino MA, Holsten S, Sakamoto C, Tateishi T, Yajima H, Duong T, de Wolf B, Gee R, Bharucha-Goebel DX, Bravver E, Mori-Yoshimura M, Bushby K, Rufibach LE, Straub V, Lowes LP, Jain COS Consortium.. Comparison of strength testing modalities in dysferlinopathy. Muscle Nerve. 2022 May 4;  

                


                  Contesse MG, Lowes LP, White MK, Dalle Pazze L, McSherry C, Alfano LN, Iammarino M, Reash N, Bonarrigo K, Kiefer M, Laubscher K, McIntyre M, Mockler S, Nelson L, Vogel L, Leffler MG. Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy. PLoS One. 2022; 17: e0266845.

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  James MK, Rose K, Alfano LN, Reash NF, Eagle M, Lowes LP. Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic. Front Genet. 2021; 12: 735538.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Mendell JR, Chicoine LG, Al-Zaidy SA, Sahenk Z, Lehman K, Lowes L, Miller N, Alfano L, Galliers B, Lewis S, Murrey D, Peterson E, Griffin DA, Church K, Cheatham S, Cheatham J, Hogan MJ, Rodino-Klapac LR. Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb Infusion. Hum Gene Ther. 2019 Apr 19;  

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Mendell JR, Sahenk Z, Al-Zaidy S, Rodino-Klapac LR, Lowes LP, Alfano LN, Berry K, Miller N, Yalvac M, Dvorchik I, Moore-Clingenpeel M, Flanigan KM, Church K, Shontz K, Curry C, Lewis S, McColly M, Hogan MJ, Kaspar BK. Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes. Mol Ther. 2017 Apr 5; 25: 870-879.

View More Publications

Research

Publications

                  James MK, Alfano LN, Muni-Lofra R, Reash NF, Sodhi J, Iammarino MA, Moat D, Shannon K, McCallum M, Richardson M, Eagle M, Straub V, Marini-Bettolo C, Lowes LP, Mayhew AG. Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies. Phys Ther. 2022 Aug 6;  

                


                  Reash NF, James MK, Alfano LN, Mayhew AG, Jacobs M, Iammarino MA, Holsten S, Sakamoto C, Tateishi T, Yajima H, Duong T, de Wolf B, Gee R, Bharucha-Goebel DX, Bravver E, Mori-Yoshimura M, Bushby K, Rufibach LE, Straub V, Lowes LP, Jain COS Consortium.. Comparison of strength testing modalities in dysferlinopathy. Muscle Nerve. 2022 May 4;  

                


                  Contesse MG, Lowes LP, White MK, Dalle Pazze L, McSherry C, Alfano LN, Iammarino M, Reash N, Bonarrigo K, Kiefer M, Laubscher K, McIntyre M, Mockler S, Nelson L, Vogel L, Leffler MG. Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy. PLoS One. 2022; 17: e0266845.

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  James MK, Rose K, Alfano LN, Reash NF, Eagle M, Lowes LP. Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic. Front Genet. 2021; 12: 735538.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Mendell JR, Chicoine LG, Al-Zaidy SA, Sahenk Z, Lehman K, Lowes L, Miller N, Alfano L, Galliers B, Lewis S, Murrey D, Peterson E, Griffin DA, Church K, Cheatham S, Cheatham J, Hogan MJ, Rodino-Klapac LR. Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb Infusion. Hum Gene Ther. 2019 Apr 19;  

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Mendell JR, Sahenk Z, Al-Zaidy S, Rodino-Klapac LR, Lowes LP, Alfano LN, Berry K, Miller N, Yalvac M, Dvorchik I, Moore-Clingenpeel M, Flanigan KM, Church K, Shontz K, Curry C, Lewis S, McColly M, Hogan MJ, Kaspar BK. Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes. Mol Ther. 2017 Apr 5; 25: 870-879.

View More Publications

Research

Publications

                  James MK, Alfano LN, Muni-Lofra R, Reash NF, Sodhi J, Iammarino MA, Moat D, Shannon K, McCallum M, Richardson M, Eagle M, Straub V, Marini-Bettolo C, Lowes LP, Mayhew AG. Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies. Phys Ther. 2022 Aug 6;  

                


                  Reash NF, James MK, Alfano LN, Mayhew AG, Jacobs M, Iammarino MA, Holsten S, Sakamoto C, Tateishi T, Yajima H, Duong T, de Wolf B, Gee R, Bharucha-Goebel DX, Bravver E, Mori-Yoshimura M, Bushby K, Rufibach LE, Straub V, Lowes LP, Jain COS Consortium.. Comparison of strength testing modalities in dysferlinopathy. Muscle Nerve. 2022 May 4;  

                


                  Contesse MG, Lowes LP, White MK, Dalle Pazze L, McSherry C, Alfano LN, Iammarino M, Reash N, Bonarrigo K, Kiefer M, Laubscher K, McIntyre M, Mockler S, Nelson L, Vogel L, Leffler MG. Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy. PLoS One. 2022; 17: e0266845.

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  James MK, Rose K, Alfano LN, Reash NF, Eagle M, Lowes LP. Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic. Front Genet. 2021; 12: 735538.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Mendell JR, Chicoine LG, Al-Zaidy SA, Sahenk Z, Lehman K, Lowes L, Miller N, Alfano L, Galliers B, Lewis S, Murrey D, Peterson E, Griffin DA, Church K, Cheatham S, Cheatham J, Hogan MJ, Rodino-Klapac LR. Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb Infusion. Hum Gene Ther. 2019 Apr 19;  

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Mendell JR, Sahenk Z, Al-Zaidy S, Rodino-Klapac LR, Lowes LP, Alfano LN, Berry K, Miller N, Yalvac M, Dvorchik I, Moore-Clingenpeel M, Flanigan KM, Church K, Shontz K, Curry C, Lewis S, McColly M, Hogan MJ, Kaspar BK. Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes. Mol Ther. 2017 Apr 5; 25: 870-879.

View More Publications

Publications

                  James MK, Alfano LN, Muni-Lofra R, Reash NF, Sodhi J, Iammarino MA, Moat D, Shannon K, McCallum M, Richardson M, Eagle M, Straub V, Marini-Bettolo C, Lowes LP, Mayhew AG. Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies. Phys Ther. 2022 Aug 6;  

                


                  Reash NF, James MK, Alfano LN, Mayhew AG, Jacobs M, Iammarino MA, Holsten S, Sakamoto C, Tateishi T, Yajima H, Duong T, de Wolf B, Gee R, Bharucha-Goebel DX, Bravver E, Mori-Yoshimura M, Bushby K, Rufibach LE, Straub V, Lowes LP, Jain COS Consortium.. Comparison of strength testing modalities in dysferlinopathy. Muscle Nerve. 2022 May 4;  

                


                  Contesse MG, Lowes LP, White MK, Dalle Pazze L, McSherry C, Alfano LN, Iammarino M, Reash N, Bonarrigo K, Kiefer M, Laubscher K, McIntyre M, Mockler S, Nelson L, Vogel L, Leffler MG. Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy. PLoS One. 2022; 17: e0266845.

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  James MK, Rose K, Alfano LN, Reash NF, Eagle M, Lowes LP. Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic. Front Genet. 2021; 12: 735538.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Mendell JR, Chicoine LG, Al-Zaidy SA, Sahenk Z, Lehman K, Lowes L, Miller N, Alfano L, Galliers B, Lewis S, Murrey D, Peterson E, Griffin DA, Church K, Cheatham S, Cheatham J, Hogan MJ, Rodino-Klapac LR. Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb Infusion. Hum Gene Ther. 2019 Apr 19;  

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Mendell JR, Sahenk Z, Al-Zaidy S, Rodino-Klapac LR, Lowes LP, Alfano LN, Berry K, Miller N, Yalvac M, Dvorchik I, Moore-Clingenpeel M, Flanigan KM, Church K, Shontz K, Curry C, Lewis S, McColly M, Hogan MJ, Kaspar BK. Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes. Mol Ther. 2017 Apr 5; 25: 870-879.

View More Publications

                  James MK, Alfano LN, Muni-Lofra R, Reash NF, Sodhi J, Iammarino MA, Moat D, Shannon K, McCallum M, Richardson M, Eagle M, Straub V, Marini-Bettolo C, Lowes LP, Mayhew AG. Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies. Phys Ther. 2022 Aug 6;  

                


                  Reash NF, James MK, Alfano LN, Mayhew AG, Jacobs M, Iammarino MA, Holsten S, Sakamoto C, Tateishi T, Yajima H, Duong T, de Wolf B, Gee R, Bharucha-Goebel DX, Bravver E, Mori-Yoshimura M, Bushby K, Rufibach LE, Straub V, Lowes LP, Jain COS Consortium.. Comparison of strength testing modalities in dysferlinopathy. Muscle Nerve. 2022 May 4;  

                


                  Contesse MG, Lowes LP, White MK, Dalle Pazze L, McSherry C, Alfano LN, Iammarino M, Reash N, Bonarrigo K, Kiefer M, Laubscher K, McIntyre M, Mockler S, Nelson L, Vogel L, Leffler MG. Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy. PLoS One. 2022; 17: e0266845.

                


                  Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.

                


                  Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.

                


                  James MK, Rose K, Alfano LN, Reash NF, Eagle M, Lowes LP. Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic. Front Genet. 2021; 12: 735538.

                


                  Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.

                


                  Mendell JR, Chicoine LG, Al-Zaidy SA, Sahenk Z, Lehman K, Lowes L, Miller N, Alfano L, Galliers B, Lewis S, Murrey D, Peterson E, Griffin DA, Church K, Cheatham S, Cheatham J, Hogan MJ, Rodino-Klapac LR. Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb Infusion. Hum Gene Ther. 2019 Apr 19;  

                


                  Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.

                


                  Mendell JR, Sahenk Z, Al-Zaidy S, Rodino-Klapac LR, Lowes LP, Alfano LN, Berry K, Miller N, Yalvac M, Dvorchik I, Moore-Clingenpeel M, Flanigan KM, Church K, Shontz K, Curry C, Lewis S, McColly M, Hogan MJ, Kaspar BK. Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes. Mol Ther. 2017 Apr 5; 25: 870-879.

View More Publications

  • James MK, Alfano LN, Muni-Lofra R, Reash NF, Sodhi J, Iammarino MA, Moat D, Shannon K, McCallum M, Richardson M, Eagle M, Straub V, Marini-Bettolo C, Lowes LP, Mayhew AG. Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies. Phys Ther. 2022 Aug 6;
  • Reash NF, James MK, Alfano LN, Mayhew AG, Jacobs M, Iammarino MA, Holsten S, Sakamoto C, Tateishi T, Yajima H, Duong T, de Wolf B, Gee R, Bharucha-Goebel DX, Bravver E, Mori-Yoshimura M, Bushby K, Rufibach LE, Straub V, Lowes LP, Jain COS Consortium.. Comparison of strength testing modalities in dysferlinopathy. Muscle Nerve. 2022 May 4;
  • Contesse MG, Lowes LP, White MK, Dalle Pazze L, McSherry C, Alfano LN, Iammarino M, Reash N, Bonarrigo K, Kiefer M, Laubscher K, McIntyre M, Mockler S, Nelson L, Vogel L, Leffler MG. Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy. PLoS One. 2022; 17: e0266845.
  • Alfano LN, Iammarino MA, Reash NF, Powers BR, Shannon K, Connolly AM, Waldrop MA, Noritz GH, Shell R, Tsao CY, Flanigan KM, Mendell JR, Lowes LP. Validity and Reliability of the Neuromuscular Gross Motor Outcome. Pediatr Neurol. 2021 Sep; 122: 21-26.
  • Mendell JR, Al-Zaidy SA, Lehman KJ, McColly M, Lowes LP, Alfano LN, Reash NF, Iammarino MA, Church KR, Kleyn A, Meriggioli MN, Shell R. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 2021 Jul 1; 78: 834-841.
  • James MK, Rose K, Alfano LN, Reash NF, Eagle M, Lowes LP. Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic. Front Genet. 2021; 12: 735538.
  • Alfano LN, Miller NF, Iammarino MA, Moore Clingenpeel M, Lowes SL, Dugan ME, Kissel JT, Al Zaidy S, Tsao CY, Lowes LP. ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy. Dev Med Child Neurol. 2020 Mar; 62: 303-309.
  • Mendell JR, Chicoine LG, Al-Zaidy SA, Sahenk Z, Lehman K, Lowes L, Miller N, Alfano L, Galliers B, Lewis S, Murrey D, Peterson E, Griffin DA, Church K, Cheatham S, Cheatham J, Hogan MJ, Rodino-Klapac LR. Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D by Isolated Limb Infusion. Hum Gene Ther. 2019 Apr 19;
  • Alfano LN, Miller NF, Berry KM, Yin H, Rolf KE, Flanigan KM, Mendell JR, Lowes LP. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials. Neuromuscul Disord. 2017 May; 27: 452-457.
  • Mendell JR, Sahenk Z, Al-Zaidy S, Rodino-Klapac LR, Lowes LP, Alfano LN, Berry K, Miller N, Yalvac M, Dvorchik I, Moore-Clingenpeel M, Flanigan KM, Church K, Shontz K, Curry C, Lewis S, McColly M, Hogan MJ, Kaspar BK. Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes. Mol Ther. 2017 Apr 5; 25: 870-879.

Contact Information

Clinical Therapies

Call us at: (614)722-6881

Fax us at: (614)722-6746

                    700 Children's Dr.Columbus, OH 43205 (map)

Contact Information

Clinical Therapies

Call us at: (614)722-6881

Fax us at: (614)722-6746

                    700 Children's Dr.Columbus, OH 43205 (map)

Contact Information

Clinical Therapies

Call us at: (614)722-6881

Fax us at: (614)722-6746

                    700 Children's Dr.Columbus, OH 43205 (map)

Clinical Therapies

Call us at: (614)722-6881

Fax us at: (614)722-6746

                    700 Children's Dr.Columbus, OH 43205 (map)

Call us at: (614)722-6881

Fax us at: (614)722-6746

                    700 Children's Dr.Columbus, OH 43205 (map)

Call us at: (614)722-6881

Fax us at: (614)722-6746

                    700 Children's Dr.Columbus, OH 43205 (map)
  • Call us at:
  • (614)722-6881
  • Fax us at:
  • (614)722-6746
  • 700 Children’s Dr.Columbus, OH 43205 (map)